Melissa Byrd

Passionate patient advocate, medical device marketer, digital marketing champion, former clinical RD. Views are my own and not those of my employer @AtriCure

[AtriCure, Inc. @AtriCure]

At #ISLAA2026, we’re connecting with physicians to share the latest in LAA exclusion, including the AtriClip PRO-Mini® — our smallest clip for minimally invasive procedures with optimized visualization and reliable, permanent LAAE. Learn more: https://t.co/y4rYN497di

@IslaaFoundation

#LAAExclusion #AtriClip #CardioTwitter

[AtriCure, Inc. @AtriCure]

Leading the way in LAA exclusion, AtriClip is setting the standard worldwide.

Learn more about the AtriClip® device portfolio at: https://t.co/8pIMEN4Yw0 ​

#AtriClip #LAAExclusion

[Melissa Byrd @TweetyByrdM]

Appreciate all of my terrific colleagues at #thisisatricure Employee Appreciation Day!

[AtriCure, Inc. @AtriCure]

At AtriCure, we’ve spent over two decades advancing left atrial appendage exclusion (LAAE) solutions.

Discover our latest breakthrough—the AtriClip FLEX-Mini® Device: https://t.co/JSQCa6T3Ri

#LAAExclusion #CardioTwitter #AtriClip

[AtriCure, Inc. @AtriCure]

In the TRAC-AF Registry, 327 patients underwent surgical ablation with the EnCompass Clamp and LAA exclusion with an AtriClip® device during concomitant open-heart surgery. Results demonstrated strong atrial arrhythmia freedom and survival outcomes.

Read the full article: https://t.co/SrRXxNMP8X

[Melissa Byrd @TweetyByrdM]

Treating Afib during CABG not only saves lives but also improves quality of life. https://t.co/IIxzxymX7v

[Melissa Byrd @TweetyByrdM]

AtriClip continues to set the standard in LAA exclusion worldwide. Visit us at #STS2026 to learn about our latest innovation, the AtriClip Mini, designed for both open and minimally invasive procedures.

[AtriCure, Inc. @AtriCure]

Over 750,000 patients treated, and 20+ years of innovation make AtriClip the global leader in left atrial appendage exclusion. ​

Stop by booth 801 at #STS2026 to learn more about our extensive portfolio or by visiting: https://t.co/QpsPwOmfci ​

#AtriClip #LAAExclusion

[Melissa Byrd @TweetyByrdM]

I’m proud to be part of AtriCure, where 750,000 patients have been treated with an AtriClip device and more than 20 years of innovation have shaped the future of LAA exclusion. I’ll be at booth 801 at #STS2026 to share more about our device portfolio. https://t.co/oXjDn0ukPO

[Melissa Byrd @TweetyByrdM]

@RpsAgainstTrump It’s unbelievable what’s happening. But if everyone who isn’t white is intimidated or afraid to show up to the polls, then a part of the agenda will be met.

[Enezator @Enezator]

He’s not a baby anymore… The moment he said goodbye to his pacifier truly went down in history. 👶🫶

[AtriCure, Inc. @AtriCure]

Thanks to the dedication of our employees, we reached significant milestones in 2025. From completing enrollment in the largest clinical trial in cardiac surgery history to recognition as a Top Workplace, we’re proud of what we achieved in 2025 and look forward to what’s ahead in 2026. #ThisisAtriCure

[AtriCure, Inc. @AtriCure]

Decades of trusted innovation for both open and minimally invasive procedures.​

The AtriClip portfolio offers solutions for diverse patient needs and surgical techniques for secure, reliable LAAE backed by clinical evidence.​​

Learn more at #STS2026 or by visiting: https://t.co/4fLKXF1mVQ ​

#AtriClip #LAAExclusion

[AtriCure, Inc. @AtriCure]

When space is limited, performance matters. The AtriClip PRO-Mini® device delivers unmatched precision with optimized visualization.
​​
Discover the latest in a large offering of AtriClip devices, the AtriClip PRO-Mini device for minimally invasive LAAE surgical procedures: https://t.co/lQsiC3ZMH2 ​

#AtriClip #LAAE #CardioTwitter

[Melissa Byrd @TweetyByrdM]

AtriClip continues to set the standard in LAA exclusion worldwide. Visit us at #STS2026 to learn about our latest innovation, the AtriClip Mini, designed for both open and minimally invasive procedures. https://t.co/P0TkCb9rZF

#AtriClip #LAAExclusion

[Melissa Byrd @TweetyByrdM]

Take 60 seconds to manage post-op pain with the cryoSPHERE MAX probe! Visit the @AtriCure booth (801) at #STS2026 to see how it’s improving recovery for cardiac & thoracic patients.

[Melissa Byrd @TweetyByrdM]

I’m excited to connect with colleagues at #STS2026 and talk about how AtriClip is advancing LAA exclusion worldwide. Stop by (booth 801) to learn about the AtriClip Mini and our full portfolio for LAAE.

[AtriCure, Inc. @AtriCure]

AtriCure is pleased to announce the first patients have been treated with our novel dual energy platform that integrates PFA with Advanced RFA. The new platform delivers the benefits of both technologies; building on our innovative EnCompass clamp technology. This device is available for investigational use only.

Learn more: https://t.co/7vOP54pBE9

[AtriCure, Inc. @AtriCure]

Pain management can be more effective in preventing chronic pain if addressed early, or better yet, before pain signals can be sent to the brain. Cryo Nerve Block is a non-pharmacological approach used during surgery to treat post-op pain.

[AtriCure, Inc. @AtriCure]

90% untreated. CABG patients are the largest group of open concomitant surgery patients. Yet only 10% receive surgical ablation. ​

The gap is massive, and lives are at risk.​

Normal sinus rhythm isn’t optional — it’s necessary.